Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 11:35AM ET
6.00
Dollar change
-0.24
Percentage change
-3.85
%
IndexRUT P/E- EPS (ttm)-1.07 Insider Own4.00% Shs Outstand205.77M Perf Week-7.41%
Market Cap1.24B Forward P/E- EPS next Y-0.36 Insider Trans2.13% Shs Float198.12M Perf Month-4.46%
Income-208.59M PEG- EPS next Q-0.17 Inst Own86.61% Short Float18.26% Perf Quarter11.94%
Sales355.39M P/S3.48 EPS this Y47.50% Inst Trans-1.64% Short Ratio10.23 Perf Half Y-3.07%
Book/sh-2.31 P/B- EPS next Y42.00% ROA-42.67% Short Interest36.18M Perf Year-19.03%
Cash/sh1.64 P/C3.66 EPS next 5Y44.80% ROE- 52W Range4.03 - 7.95 Perf YTD0.17%
Dividend Est.- P/FCF- EPS past 5Y-3.73% ROI-59.94% 52W High-24.53% Beta1.88
Dividend TTM- Quick Ratio3.48 Sales past 5Y190.00% Gross Margin98.12% 52W Low48.88% ATR (14)0.35
Dividend Ex-Date- Current Ratio3.73 EPS Y/Y TTM11.90% Oper. Margin-25.26% RSI (14)47.51 Volatility5.11% 5.46%
Employees536 Debt/Eq- Sales Y/Y TTM22.68% Profit Margin-58.69% Recom1.33 Target Price14.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q39.31% Payout- Rel Volume0.52 Prev Close6.24
Sales Surprise8.34% EPS Surprise18.78% Sales Q/Q34.87% EarningsMay 06 BMO Avg Volume3.54M Price6.00
SMA20-6.29% SMA509.25% SMA2003.76% Trades Volume647,587 Change-3.85%
Date Action Analyst Rating Change Price Target Change
Nov-20-23Resumed JP Morgan Overweight $10
Sep-18-23Upgrade RBC Capital Mkts Sector Perform → Outperform $9 → $10
Aug-04-23Upgrade Jefferies Hold → Buy $11
Jul-13-23Upgrade BofA Securities Neutral → Buy $10
Feb-22-23Upgrade Needham Hold → Buy $14
Nov-02-22Upgrade Evercore ISI In-line → Outperform $14 → $16
Aug-05-22Downgrade Oppenheimer Outperform → Perform
Aug-05-22Downgrade Evercore ISI Outperform → In-line $14
Apr-18-22Downgrade Barclays Overweight → Equal Weight $22 → $13
Apr-11-22Downgrade BofA Securities Buy → Neutral $21 → $14
Jun-04-24 07:00AM
Jun-02-24 04:00AM
May-15-24 01:13PM
11:00AM
11:00AM
11:00AM Loading…
11:00AM
11:00AM
May-14-24 07:00AM
May-13-24 10:31AM
07:00AM
May-09-24 07:00AM
May-07-24 11:51AM
10:50AM
07:00AM
03:01AM
01:13AM Loading…
01:13AM
May-06-24 06:47PM
04:59PM
01:00PM
12:35PM
12:35PM
11:53AM
11:45AM
08:32AM
08:10AM
07:10AM
07:00AM
May-03-24 07:00AM
Apr-29-24 10:00AM
Apr-22-24 07:00AM
05:14AM Loading…
Apr-17-24 05:14AM
04:30AM
Apr-10-24 06:09PM
Apr-03-24 07:00AM
Mar-25-24 04:01PM
Mar-13-24 07:07AM
Mar-05-24 07:01AM
Mar-01-24 08:29AM
Feb-28-24 10:47AM
Feb-27-24 04:05AM
Feb-26-24 04:45PM
08:10AM
07:32AM
07:09AM
07:00AM
Feb-23-24 07:00AM
Feb-21-24 04:01PM
Feb-19-24 07:54AM
Feb-12-24 07:00AM
Feb-05-24 07:00AM
Feb-02-24 07:00AM
Jan-09-24 09:25AM
Jan-05-24 04:01PM
Jan-03-24 04:01PM
07:00AM
Dec-19-23 07:00AM
Dec-05-23 04:01PM
Nov-30-23 08:42AM
Nov-29-23 07:00AM
Nov-21-23 04:01PM
07:00AM
Nov-10-23 07:00AM
Nov-06-23 04:01PM
Nov-03-23 12:03PM
12:00PM
11:28AM
05:31AM
Nov-02-23 08:53AM
07:17AM
07:00AM
Oct-27-23 07:00AM
Oct-26-23 07:00AM
Oct-20-23 07:00AM
Oct-19-23 07:00AM
Oct-04-23 07:00AM
Sep-18-23 07:00AM
Sep-05-23 07:00AM
Aug-28-23 08:30AM
Aug-23-23 04:01PM
Aug-04-23 04:56PM
04:01PM
Aug-03-23 02:30PM
08:15AM
07:07AM
07:00AM
Jul-20-23 09:55AM
07:00AM
Jul-19-23 07:00AM
Jul-18-23 09:42AM
Jul-17-23 07:00AM
Jul-13-23 09:43AM
Jul-06-23 07:00AM
Jul-03-23 04:23AM
Jun-06-23 07:00AM
Jun-01-23 07:00AM
May-31-23 07:02AM
May-22-23 07:00AM
May-09-23 10:21AM
May-04-23 04:01PM
May-03-23 02:00PM
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SANDERS MACHELLEDirectorJun 17 '24Sale6.004,68928,13427,742Jun 17 04:31 PM
HEGGIE THERESADirectorJun 14 '24Sale6.116,69840,92552,852Jun 14 04:25 PM
LEVIN ALAN GDirectorMay 30 '24Buy6.367,86149,99644,951May 31 04:25 PM
ASELAGE STEVEDirectorMay 24 '24Buy6.402,50016,0002,500May 29 04:16 PM
MILANO VINCENTDirectorMay 20 '24Buy6.2515,00093,75066,997May 22 07:21 AM
Hutson Nancy JDirectorMay 20 '24Buy6.385,00031,90086,818May 22 07:24 AM
Doyle AnthonyChief Financial OfficerMay 14 '24Buy5.5736,300202,191266,744May 15 07:19 AM
Thackray Helen M.Chief R&D OfficerMay 14 '24Buy5.8630,000175,800272,139May 15 07:17 AM
Stonehouse Jon PPresident & CEOMay 13 '24Buy5.5530,000166,5001,127,770May 15 07:08 AM
Gayer Charles KChief Commercial OfficerMay 13 '24Buy5.4730,000164,100307,533May 15 07:04 AM
Galson Steven KDirectorMay 13 '24Buy5.4921,940120,45151,551May 15 07:14 AM
Barnes Alane PChief Legal OfficerMay 13 '24Buy5.535,00027,650300,762May 15 07:11 AM